Endocrinology - Diabetes News & Articles

MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.

Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Endocrinology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

Articles

Latest (22) Full Text Articles (1230) Focus on Diabetes

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

81 Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND Journal of Diabetes and its Complications, May 16, 2013 Clinical Article

82 Rehabilitation outcomes of stroke patients with and without diabetes Archives of Physical Medicine and Rehabilitation, May 16, 2013 Clinical Article

83 Self-rated health predicts outcome in patients with type 2 diabetes and myocardial infarction: A DIGAMI 2 quality of life sub-study Diabetes & Vascular Disease Research, May 16, 2013 Review Article

84 Prevention of obesity and diabetes in childbearing women Journal of Midwifery and Women's Health, May 16, 2013 Clinical Article

85 Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome Diabetes & Vascular Disease Research, May 16, 2013 Review Article

86 Detecting intentional insulin omission for weight loss in girls with type 1 diabetes mellitus International Journal of Eating Disorders, May 16, 2013 Clinical Article

87 Diabetes mellitus, but not small dense low-density lipoprotein, is predictive of cardiovascular disease: A Korean community-based prospective cohort study Journal of Diabetes Investigation, May 16, 2013 Clinical Article

88 Anti-neurotrophic effects from autoantibodies in adult diabetes having primary open angle glaucoma or dementia Frontiers in Endocrinology, May 16, 2013 Review Article

89 Interconception care for women with prior gestational diabetes mellitus Journal of Midwifery and Women's Health, May 16, 2013 Clinical Article

90 Genetic modifiers of cystic fibrosis-related diabetes Diabetes, May 16, 2013 Review Article
Exclusive Author Commentary

91 Euglycaemic ketoacidosis in patients with and without diabetes Practical Diabetes, May 16, 2013 Review Article

92 The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010 Diabetes, Obesity and Metabolism, May 16, 2013 Clinical Article

93 Relationship between serum levels of triglycerides and vascular inflammation, measured as COX-2, in arteries from diabetic patients: a translational study Full Text Lipids in Health and Disease, May 16, 2013 Clinical Article

94 Continuous on-line glucose measurement by microdialysis in a central vein. A pilot study Critical Care, May 16, 2013 Clinical Article

95 How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus The European Journal of Health Economics, May 16, 2013 Review Article

96 Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina Investigative Ophthalmology & Visual Science, May 16, 2013 Review Article

97 A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes Diabetic Medicine, May 15, 2013 Clinical Article

98 Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial Full Text BMC Public Health, May 15, 2013 Clinical Article

99 Changes in Body Fat Distribution and Fitness Are Associated With Changes in Hemoglobin A_1c After 9 Months of Exercise Training: Results From the HART-D Study Diabetes Care, May 15, 2013 Clinical Article

100 Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report Full Text Cardiovascular Diabetology, May 15, 2013 Clinical Article

50 available pages First Previous 5 6 7 8 9 10 11 12 13 14 Next Last

Clinical Pearls in Endocrinology

Pioglitazone can reduce the risk of conversion of impaired glucose tolerance to type 2 diabetes mellitus by 72%, but it was also associated with significant weight gain and edema
The most commonly reported adverse event associated with Janumet in the treatment of type 2 diabetes is diarrhea, followed by upper respiratory tract infection and headache
Maturity-onset diabetes of the young (MODY)3 can be treated with sulfonylureas with excellent results for decades

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Endocrinology

Regulatory protein identified in T1DM

As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.

Read the article summary

Statins increase risk of DM in postmenopausal women

As reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up

Read the article summary

Determining the basal insulin dosage in T2DM

Anthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Endocrinology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Endocrinology - Diabetes News & Articles

Articles

Clinical Pearls in Endocrinology

Highlights in Endocrinology

Regulatory protein identified in T1DM

Statins increase risk of DM in postmenopausal women

Determining the basal insulin dosage in T2DM

Most Popular Endocrinology Articles

Other Topics in Endocrinology